Vitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats. The direct segment sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com. The manufacturing segment provides custom manufacturing and private labeling of vitamin, mineral and supplement products, and develops and markets its own branded products for both sales to third parties and for the VSI product assortment. As of December 31, 2016, it marketed approximately 900 brands, as well as its own brands. As of December 31, 2016, it operated 775 stores located in 45 states, the District of Columbia and Puerto Rico, primarily located in retail centers and standalone locations.
Industry, Sector and Symbol:
- Sector: Retail/Wholesale
- Industry: Health Food Stores
- Sub-Industry: Specialty Stores
- Symbol: NYSE:VSI
- CUSIP: 92849E10
- Web: www.vitaminshoppe.com
Capitalization:- Market Cap: $143.93 million
- Outstanding Shares: 23,223,000
Average Prices:- 50 Day Moving Avg: $6.69
- 200 Day Moving Avg: $13.12
- 52 Week Range: $4.95 - $28.41
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 8.12
- P/E Growth: -0.22
Sales & Book Value:- Annual Revenue: $1.24 billion
- Price / Sales: 0.10
- Book Value: $12.73 per share
- Price / Book: 0.44
Profitability:- EBIDTA: $99.96 million
- Net Margins: -11.98%
- Return on Equity: 8.33%
- Return on Assets: 4.92%
Debt:- Debt-to-Equity Ratio: 0.42%
- Current Ratio: 2.27%
- Quick Ratio: 0.34%
Misc:- Average Volume: 675,662 shs.
- Beta: 0.78
- Short Ratio: 11.37
Frequently Asked Questions for Vitamin Shoppe (NYSE:VSI)
What is Vitamin Shoppe's stock symbol?
Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."
How were Vitamin Shoppe's earnings last quarter?
Vitamin Shoppe, Inc (NYSE:VSI) released its quarterly earnings results on Wednesday, August, 9th. The company reported $0.23 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.39 by $0.16. The firm had revenue of $304.84 million for the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business's revenue for the quarter was down 8.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.55 earnings per share. View Vitamin Shoppe's Earnings History.
When will Vitamin Shoppe make its next earnings announcement?
Where is Vitamin Shoppe's stock going? Where will Vitamin Shoppe's stock price be in 2017?
8 equities research analysts have issued 12-month price targets for Vitamin Shoppe's shares. Their predictions range from $5.00 to $28.00. On average, they anticipate Vitamin Shoppe's share price to reach $12.57 in the next year. View Analyst Ratings for Vitamin Shoppe.
Who are some of Vitamin Shoppe's key competitors?
Some companies that are related to Vitamin Shoppe include Hibbett Sports (HIBB), Fred's (FRED), Citi Trends (CTRN), Zoe's Kitchen (ZOES), Tecnoglass (TGLS), Boot Barn Holdings (BOOT), Sportsman's Warehouse Holdings (SPWH), Kirkland's (KIRK), Noodles & Company (NDLS), Big 5 Sporting Goods Corporation (BGFV), Build-A-Bear Workshop (BBW), Jamba (JMBA), Ruby Tuesday (RT), Natural Grocers by Vitamin Cottage (NGVC), New York & Company (NWY), Tuesday Morning Corp. (TUES), U.S. Auto Parts Network (PRTS) and Travelzoo (TZOO).
Who are Vitamin Shoppe's key executives?
Vitamin Shoppe's management team includes the folowing people:
- Colin Frederick Watts, Chief Executive Officer, Director
- Brenda M. Galgano CPA, Chief Financial Officer, Executive Vice President
- Michael A. Jaffe, Interim General Counsel, Corporate Secretary
- John D. Bowlin, Lead Independnt Director
- B. Michael Michael Becker CPA, Independent Director
- Deborah M. Derby, Independent Director
- Tracy Dolgin, Independent Director
- David H. Edwab CPA, Independent Director
Who owns Vitamin Shoppe stock?
Vitamin Shoppe's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.66%), Eagle Asset Management Inc. (6.61%), Vanguard Group Inc. (5.83%), FMR LLC (5.42%),
CARLSON CAPITAL L P
(4.97%) and State Street Corp (2.66%). Company insiders that own Vitamin Shoppe stock include B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin and Richard L Markee. View Institutional Ownership Trends for Vitamin Shoppe.
Who sold Vitamin Shoppe stock? Who is selling Vitamin Shoppe stock?
Vitamin Shoppe's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Eagle Asset Management Inc., Ameriprise Financial Inc., State Street Corp, Menta Capital LLC, Wells Fargo & Company MN, Prudential Financial Inc. and Thrivent Financial For Lutherans. Company insiders that have sold Vitamin Shoppe stock in the last year include B Michael Becker, Dan Lamadrid and Richard L Markee. View Insider Buying and Selling for Vitamin Shoppe.
Who bought Vitamin Shoppe stock? Who is buying Vitamin Shoppe stock?
Vitamin Shoppe's stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Canada Pension Plan Investment Board, Los Angeles Capital Management & Equity Research Inc., Schwab Charles Investment Management Inc., Financial & Investment Management Group Ltd., Goldman Sachs Group Inc., Parametric Portfolio Associates LLC and Systematic Financial Management LP. Company insiders that have bought Vitamin Shoppe stock in the last two years include Guillermo Marmol and John D Bowlin. View Insider Buying and Selling for Vitamin Shoppe.
How do I buy Vitamin Shoppe stock?
Shares of Vitamin Shoppe can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vitamin Shoppe's stock price today?
One share of Vitamin Shoppe stock can currently be purchased for approximately $5.60.
MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Vitamin Shoppe (NYSE:VSI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Sell Ratings, 6 Hold Ratings |
| Consensus Rating: | Hold (Score: 1.75) |
| Consensus Price Target: | $12.57 (124.49% upside) |
Analysts' Ratings History for Vitamin Shoppe (NYSE:VSI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/23/2017 | Bank of America Corporation | Reiterated Rating | Underperform | $5.50 -> $5.00 | Low |  |
| 8/10/2017 | Morgan Stanley | Set Price Target | Hold | $14.00 -> $8.00 | Medium | |
| 8/10/2017 | Goldman Sachs Group, Inc. (The) | Reiterated Rating | Sell | $13.00 -> $6.00 | Medium | |
| 8/10/2017 | Deutsche Bank AG | Reiterated Rating | Hold | $14.00 -> $7.00 | High | |
| 8/10/2017 | Barclays PLC | Lower Price Target | Equal Weight | $13.00 -> $6.00 | High | |
| 5/11/2017 | Gabelli | Downgrade | Buy -> Hold | | Medium | |
| 10/27/2016 | J P Morgan Chase & Co | Downgrade | Overweight -> Neutral | $33.00 -> $28.00 | N/A | |
| 9/26/2016 | Jefferies Group LLC | Reiterated Rating | Hold | $28.00 | N/A | |
| 8/3/2016 | Wedbush | Reiterated Rating | Outperform | $39.00 | N/A | |
| 5/16/2016 | Robert W. Baird | Reiterated Rating | Hold | | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Neutral | | N/A | |
| 5/5/2016 | Macquarie | Reiterated Rating | Neutral | $40.00 | N/A | |
| 4/15/2016 | Piper Jaffray Companies | Reiterated Rating | Neutral | $30.00 | N/A | |
| 3/28/2016 | William Blair | Downgrade | Market Perform | | N/A | |
(Data available from 9/19/2015 forward)
Earnings History for Vitamin Shoppe (NYSE:VSI)Earnings History by Quarter for Vitamin Shoppe (NYSE VSI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/31/2017 | | $0.18 | | | | | N/A | |
| 8/9/2017 | Q2 2017 | $0.39 | $0.23 | $314.74 million | $304.84 million | View | Listen | |
| 5/10/2017 | Q1 2017 | $0.58 | $0.37 | $325.71 million | $316.90 million | View | N/A | |
| 3/1/2017 | Q416 | $0.40 | $0.36 | $311.79 million | $304.87 million | View | Listen | |
| 11/2/2016 | Q316 | $0.50 | $0.50 | $317.18 million | $314.90 million | View | N/A | |
| 8/3/2016 | Q216 | $0.59 | $0.55 | $331.58 million | $332.70 million | View | N/A | |
| 5/4/2016 | Q116 | $0.65 | $0.67 | $339.76 million | $336.80 million | View | N/A | |
| 2/23/2016 | Q415 | $0.38 | $0.39 | $294.17 million | $293.50 million | View | Listen | |
| 11/4/2015 | Q315 | $0.47 | $0.52 | $317.28 million | $313.90 million | View | N/A | |
| 8/5/2015 | Q215 | $0.54 | $0.57 | $325.78 million | $322.30 million | View | N/A | |
| 5/6/2015 | Q115 | $0.74 | $0.63 | $344.66 million | $336.80 million | View | N/A | |
| 2/24/2015 | Q414 | $0.41 | $0.41 | $294.77 million | $290.10 million | View | N/A | |
| 11/4/2014 | Q314 | $0.52 | $0.40 | $314.60 million | $308.90 million | View | N/A | |
| 8/5/2014 | Q214 | $0.63 | $0.62 | $306.09 million | $306.20 million | View | N/A | |
| 5/7/2014 | Q114 | $0.68 | $0.67 | $302.82 million | $307.80 million | View | N/A | |
| 2/25/2014 | Q413 | $0.38 | $0.37 | $253.87 million | $256.40 million | View | N/A | |
| 11/5/2013 | Q313 | $0.52 | $0.53 | $273.87 million | $272.50 million | View | N/A | |
| 8/6/2013 | Q2 2013 | $0.60 | $0.60 | $284.28 million | $279.50 million | View | Listen | |
| 5/7/2013 | Q1 2013 | $0.69 | $0.68 | $282.71 million | $279.10 million | View | Listen | |
| 2/26/2013 | Q4 2012 | $0.40 | $0.40 | $223.88 million | $218.90 million | View | Listen | |
| 11/6/2012 | Q312 | $0.46 | $0.54 | $234.66 million | $239.00 million | View | N/A | |
| 8/7/2012 | | $0.51 | $0.55 | | | View | N/A | |
| 5/8/2012 | | $0.57 | $0.61 | | | View | N/A | |
| 2/28/2012 | | $0.32 | $0.38 | | | View | N/A | |
| 10/26/2011 | | $0.33 | $0.41 | | | View | N/A | |
| 7/28/2011 | | $0.38 | $0.40 | | | View | N/A | |
| 4/26/2011 | | $0.40 | $0.47 | | | View | N/A | |
| 2/16/2011 | | $0.21 | $0.22 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Vitamin Shoppe (NYSE:VSI)2017 EPS Consensus Estimate: $2.40
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.75 | $0.79 | $0.77 |
| Q2 2017 | 2 | $0.59 | $0.64 | $0.62 |
| Q3 2017 | 2 | $0.53 | $0.57 | $0.55 |
| Q4 2017 | 2 | $0.43 | $0.50 | $0.47 |
(Data provided by Zacks Investment Research)
Dividend History for Vitamin Shoppe (NYSE:VSI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Vitamin Shoppe (NYSE:VSI)Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 96.86%
Insider Trades by Quarter for Vitamin Shoppe (NYSE:VSI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/25/2017 | John D Bowlin | Director | Buy | 40,000 | $5.50 | $220,000.00 | |
| 3/8/2017 | B. Michael Becker | Director | Sell | 2,729 | $19.41 | $52,969.89 | |
| 3/3/2017 | Dan Lamadrid | CAO | Sell | 5,432 | $22.36 | $121,459.52 | |
| 3/3/2017 | Richard L Markee | Director | Sell | 100,000 | $22.24 | $2,224,000.00 | |
| 11/8/2016 | Dan Lamadrid | CAO | Sell | 1,734 | $23.20 | $40,228.80 | |
| 5/31/2016 | Guillermo Marmol | Director | Buy | 1,000 | $30.23 | $30,230.00 | |
| 11/14/2014 | Brenda Galgano | CFO | Sell | 5,000 | $48.77 | $243,850.00 | |
| 11/13/2014 | Richard L Markee | Insider | Sell | 27,774 | $47.79 | $1,327,319.46 | |
| 9/18/2014 | Anthony N Truesdale | CEO | Sell | 61,792 | $45.00 | $2,780,640.00 | |
| 9/18/2014 | Richard L Markee | Insider | Sell | 30,000 | $45.00 | $1,350,000.00 | |
| 9/12/2014 | Jean W Frydman | Insider | Sell | 1,135 | $43.40 | $49,259.00 | |
| 6/16/2014 | Richard L Markee | Chairman | Sell | 10,000 | $45.00 | $450,000.00 | |
| 6/11/2014 | Anthony Alfonso | Insider | Buy | 5,000 | $44.44 | $222,200.00 | |
| 5/1/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $47.18 | $1,651,300.00 | |
| 5/1/2014 | Richard Markee | Chairman | Sell | 10,000 | $47.18 | $471,800.00 | |
| 4/1/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $47.91 | $1,676,850.00 | |
| 4/1/2014 | Richard Markee | Insider | Sell | 10,000 | $47.91 | $479,100.00 | |
| 3/3/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $46.30 | $1,620,500.00 | |
| 3/3/2014 | Richard Markee | Insider | Sell | 10,000 | $46.29 | $462,900.00 | |
| 1/10/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $48.51 | $1,697,850.00 | |
| 11/14/2013 | Richard Markee | Chairman | Sell | 50,000 | $52.48 | $2,624,000.00 | |
| 11/13/2013 | David Edwab | Director | Sell | 3,738 | $52.35 | $195,684.30 | |
| 2/28/2013 | B. Michael Becker | Director | Buy | 1,000 | $51.95 | $51,950.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Vitamin Shoppe (NYSE:VSI)
Latest Headlines for Vitamin Shoppe (NYSE:VSI)
| Source: |
|
| Date | Headline |
|---|
 | VSI EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Vitamin Shoppe, Inc. and a Lead Plaintiff Deadline of October 27, 2017
finance.yahoo.com - September 16 at 10:15 AM |
| EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 16 at 10:15 AM |
| INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 15 at 11:15 AM |
| ETFs with exposure to Vitamin Shoppe, Inc. : September 14, 2017
finance.yahoo.com - September 14 at 2:07 AM |
| The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Vitamin Shoppe, Inc. Shareholders and a Lead Plaintiff Deadline of October 27, 2017
finance.yahoo.com - September 13 at 4:00 PM |
| SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 13 at 4:00 PM |
| The Klein Law Firm Announces a Class Action Filed on Behalf of Vitamin Shoppe, Inc. Shareholders and a Lead Plaintiff Deadline of October 27, 2017 (VSI)
finance.yahoo.com - September 13 at 11:07 AM |
| SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 13 at 11:07 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Vitamin Shoppe, Inc. (VSI) & Lead Plaintiff Deadline - October 27, 2017
finance.yahoo.com - September 13 at 11:07 AM |
| VSI INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Vitamin Shoppe, Inc. and a Lead Plaintiff Deadline of October 27, 2017
finance.yahoo.com - September 12 at 12:00 PM |
| Vitamin Shoppe, Inc. :VSI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
finance.yahoo.com - September 12 at 12:00 PM |
| INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 12 at 12:00 PM |
 | VSI LOSS NOTICE: Rosen Law Firm Reminds Vitamin Shoppe, Inc. Investors of Important Deadline in Class Action – VSI
www.businesswire.com - September 9 at 9:48 AM |
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Vitamin Shoppe, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit
finance.yahoo.com - September 9 at 9:48 AM |
| INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Vitamin Shoppe, Inc.
finance.yahoo.com - September 9 at 9:48 AM |
 | VITAMIN SHOPPE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Vitamin Shoppe, Inc. - (VSI)
feeds.benzinga.com - September 8 at 11:57 PM |
| VSI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Vitamin Shoppe, Inc. and a Lead Plaintiff Deadline of October 27, 2017
feeds.benzinga.com - September 8 at 3:41 PM |
| INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vitamin Shoppe, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 27, 2017
finance.yahoo.com - September 8 at 10:13 AM |
| IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 8 at 10:13 AM |
 | SHAREHOLDER ALERT: SFMS Announces Filing of Securities Class Action Lawsuit Against Vitamin Shoppe, Inc.
globenewswire.com - September 7 at 10:59 AM |
 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitamin Shoppe, Inc. - VSI
www.bizjournals.com - September 7 at 10:59 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Vitamin Shoppe, Inc. (VSI) & Lead Plaintiff Deadline: October 27, 2017
finance.yahoo.com - September 7 at 10:59 AM |
| IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 7 at 10:59 AM |
| The Vitamin Shoppe's Exclusive ProBioCare® Brand Launches Innovative DUOCAP™ Technology to the U.S. Market
finance.yahoo.com - September 6 at 10:03 AM |
| The Klein Law Firm Reminds Investors of Commencement of an Investigation Concerning Possible Violations of Federal Securities Laws by Vitamin Shoppe, Inc.
finance.yahoo.com - September 6 at 10:03 AM |
| IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 6 at 10:03 AM |
 | Vitamin Shoppe, Inc (VSI) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - September 5 at 6:44 PM |
| Brokerages Anticipate Vitamin Shoppe, Inc (VSI) Will Post Quarterly Sales of $295.87 Million
www.americanbankingnews.com - September 4 at 10:58 AM |
| The Klein Law Firm Notifies Investors of Commencement of an Investigation Concerning Possible Violations of Federal Securities Laws by Vitamin Shoppe, Inc.
finance.yahoo.com - September 3 at 8:03 AM |
| IMPORTANT VITAMIN SHOPPE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of investors who purchased Vitamin Shoppe, Inc.
finance.yahoo.com - September 3 at 8:03 AM |
| IMPORTANT VITAMIN SHOPPE, INC. INVESTOR ALERT...
www.benzinga.com - September 2 at 10:18 AM |
 | VITAMIN SHOPPE INC
www.finanznachrichten.de - September 2 at 10:18 AM |
| IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 2 at 10:18 AM |
| Vitamin Shoppe, Inc (VSI) Downgraded to "Hold" at ValuEngine
www.americanbankingnews.com - September 2 at 12:06 AM |
| Robbins Geller Rudman & Dowd LLP Files Corrected Class Action Suit against Vitamin Shoppe, Inc.
www.businesswire.com - September 1 at 10:54 AM |
| VSI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Vitamin Shoppe, Inc.
finance.yahoo.com - September 1 at 10:54 AM |
| IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Vitamin Shoppe, Inc. and Encourages Investors With Losses to Contact the Firm
finance.yahoo.com - September 1 at 10:54 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Vitamin Shoppe, Inc. Investors
www.businesswire.com - August 30 at 8:53 PM |
| SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Vitamin Shoppe, Inc.
finance.yahoo.com - August 30 at 8:53 PM |
| IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 30 at 3:51 PM |
| INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Vitamin Shoppe, Inc.
finance.yahoo.com - August 30 at 3:50 PM |
| IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Vitamin Shoppe, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 30 at 3:50 PM |
| VSI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Vitamin Shoppe, Inc. (VSI)
finance.yahoo.com - August 30 at 3:50 PM |
| Scott+Scott, Attorneys at Law, LLP Announces Federal Securities Class Action Against Vitamin Shoppe, Inc. (VSI)
www.bizjournals.com - August 30 at 10:56 AM |
| Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vitamin Shoppe, Inc. (VSI) and Encourages Investors to Contact the Firm
www.businesswire.com - August 30 at 10:56 AM |
| Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Vitamin Shoppe, Inc. (VSI)
finance.yahoo.com - August 30 at 10:56 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vitamin Shoppe, Inc. Investors and Encourages Investors to Contact the Firm
finance.yahoo.com - August 30 at 10:56 AM |
| Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Vitamin Shoppe, Inc. (VSI)
feeds.benzinga.com - August 29 at 8:49 PM |
| Vitamin Shoppe, Inc (VSI) Director John D. Bowlin Purchases 40,000 Shares
www.americanbankingnews.com - August 29 at 7:40 PM |
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Vitamin Shoppe, Inc. (NYSE: VSI) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - August 29 at 7:40 PM |
Vitamin Shoppe (VSI) Chart for Tuesday, September, 19, 2017
